TABLE 3.
Absolute change from baseline to 12 mo postpartum in tibial and radial bone variables assessed by peripheral quantitative computed tomography in women receiving calcium supplementation or placebo during pregnancy1
| Time of study | P | |||||
|---|---|---|---|---|---|---|
| Dependent variable and supplement group | Visit 3 (36 wk of pregnancy; n = 53) | Visit 4 (4 mo postpartum; n = 45) | Visit 5 (12 mo postpartum; n = 30) | Group | Time | Group × time2 |
| Tibial distal metaphyseal site (3%), g/cm3 | ||||||
| Total vBMD | 0.087 | NS | NS | |||
| Calcium | −0.66 ± 2.13 | −2.34 ± 1.53 | −1.42 ± 2.19 | |||
| Placebo | −3.30 ± 1.26 | −6.48 ± 1.87 | −6.61 ± 2.53 | |||
| Trabecular vBMD | 0.067 | NS | 0.058 | |||
| Calcium | −1.41 ± 0.83 | −1.05 ± 1.18 | 0.26 ± 2.07 | |||
| Placebo | −2.58 ± 1.28 | −5.41 ± 1.77 | −6.71 ± 2.34 | |||
| Tibial proximal diaphyseal site (38%), g/cm3 | ||||||
| Total vBMD | NS | NS | 0.062 | |||
| Calcium | −3.78 ± 1.84 | −4.01 ± 6.07 | −0.71 ± 2.04 | |||
| Placebo | 1.15 ± 1.58 | 1.81 ± 1.54 | −1.51 ± 1.67 | |||
| Cortical vBMD | NS | 0.021 | 0.034 | |||
| Calcium | −1.33 ± 2.02 | 4.33 ± 1.49 | 2.27 ± 1.75 | |||
| Placebo | 0.39 ± 1.36 | 1.51 ± 1.46 | −3.55 ± 2.06 | |||
| Radial distal metaphyseal site (4%), g/cm3 | ||||||
| Total vBMD | NS | NS | NS | |||
| Calcium | −5.33 ± 6.38 | −2.82 ± 6.62 | −10.67 ± 6.34 | |||
| Placebo | −0.49 ± 4.89 | −3.43 ± 6.71 | 0.77 ± 6.51 | |||
| Trabecular vBMD | NS | 0.087 | NS | |||
| Calcium | −2.10 ± 1.35 | −1.86 ± 1.32 | −5.32 ± 1.74 | |||
| Placebo | −0.62 ± 1.02 | −1.20 ± 1.06 | −3.42 ± 2.45 | |||
| Radial proximal diaphyseal site (50%), g/cm3 | ||||||
| Total vBMD | NS | NS | 0.018 | |||
| Calcium | −7.01 ± 3.75 | −1.74 ± 2.97 | 6.74 ± 4.89 | |||
| Placebo | 1.04 ± 2.19 | 0.48 ± 2.85 | −4.23 ± 3.69 | |||
| Cortical vBMD | NS | NS | 0.053 | |||
| Calcium | −6.75 ± 4.60 | −0.83 ± 3.12 | 6.69 ± 5.74 | |||
| Placebo | −0.52 ± 3.08 | 0.09 ± 2.73 | −7.47 ± 5.01 | |||
Values are adjusted means ± SEs. Baseline values are not included in the table because they were adjusted for in the statistical models: values shown represent the change from baseline. Calcium: 1000-mg Ca supplement/d from 16 wk of gestation to delivery. Placebo: placebo daily from 16 wk of gestation to delivery. vBMD, volumetric bone mineral density.
Linear mixed models for longitudinal data were used to derive the P values after adjusting for baseline bone values, serum 25-hydroxyvitamin D, length of breastfeeding (in months), and BMI (in kg/m2).